NCT06046079 Predictors of Health Service Utilizations Among Key Population in Washington DC
| NCT ID | NCT06046079 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Us Helping Us, People Into Living, Inc. |
| Condition | Pre-exposure Prophylaxis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-08-25 |
| Primary Completion | 2025-07-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-08-25 with a primary completion date of 2025-07-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the proposed study is to investigate how PrEP use might result in an increase in the utilization of health and social services offered at a local community-based organization. Our primary hypothesis is that the investigators will observe higher utilization of sexual health (STI screenings), psychosocial health (psychotherapy, and substance use treatment) and other social services (emergency cash assistance, food pantry, transportation assistance, clothing,and housing resources) among PrEP users (LAI-PrEP or daily oral) compared to participants who are PrEP naïve over the 12-month follow-up period.
Eligibility Criteria
Inclusion Criteria: * age of 18 years or above; * confirmed HIV-negative status; * residence in the Washington, DC metropolitan area; * one of the following PrEP profiles (PrEP naïve \[no history of any PrEP use in the past\] currently on daily oral PrEP or receiving LAI-PrEP). Exclusion Criteria: * being younger than18 years of age * being unable to speak and/or read English * a reported residence outside of the defined Washington, DC metropolitan area * being unable or unwilling to provide written informed consent * being unable to comply with the requirements of the protocol (i.e. persons with mental health conditions, persons who are intoxicated or incoherent for other reasons) * evidence of suspected hepatoxicity
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06046079 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pre-exposure Prophylaxis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06046079 currently recruiting?
Yes, NCT06046079 is actively recruiting participants. Contact the research team at dhickson@uhupil.org for enrollment information.
Where is the NCT06046079 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT06046079 clinical trial?
NCT06046079 is sponsored by Us Helping Us, People Into Living, Inc.. The trial plans to enroll 100 participants.